Los Angeles Capital Management LLC Invests $7.29 Million in Omega Healthcare Investors, Inc. (NYSE:OHI)

Los Angeles Capital Management LLC acquired a new stake in shares of Omega Healthcare Investors, Inc. (NYSE:OHI) in the third quarter, HoldingsChannel reports. The firm acquired 179,184 shares of the real estate investment trust’s stock, valued at approximately $7,293,000.

Several other institutional investors also recently added to or reduced their stakes in the stock. Daiwa Securities Group Inc. lifted its position in shares of Omega Healthcare Investors by 1,030.8% in the 2nd quarter. Daiwa Securities Group Inc. now owns 945,523 shares of the real estate investment trust’s stock worth $32,384,000 after purchasing an additional 861,907 shares during the period. Marshall Wace LLP purchased a new stake in Omega Healthcare Investors in the second quarter valued at about $20,962,000. BROOKFIELD Corp ON acquired a new stake in Omega Healthcare Investors in the first quarter worth about $16,446,000. Dimensional Fund Advisors LP grew its stake in shares of Omega Healthcare Investors by 7.9% during the second quarter. Dimensional Fund Advisors LP now owns 3,732,390 shares of the real estate investment trust’s stock worth $127,831,000 after acquiring an additional 272,299 shares during the last quarter. Finally, Sei Investments Co. increased its holdings in shares of Omega Healthcare Investors by 150.8% during the second quarter. Sei Investments Co. now owns 298,761 shares of the real estate investment trust’s stock valued at $10,233,000 after acquiring an additional 179,623 shares in the last quarter. Hedge funds and other institutional investors own 65.25% of the company’s stock.

Insider Buying and Selling

In related news, CFO Robert O. Stephenson sold 22,542 shares of Omega Healthcare Investors stock in a transaction dated Friday, September 27th. The stock was sold at an average price of $40.19, for a total value of $905,962.98. Following the sale, the chief financial officer now directly owns 183,076 shares in the company, valued at approximately $7,357,824.44. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In other news, COO Daniel J. Booth sold 56,725 shares of the business’s stock in a transaction that occurred on Friday, September 27th. The stock was sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the transaction, the chief operating officer now directly owns 100,000 shares in the company, valued at $4,025,000. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Robert O. Stephenson sold 22,542 shares of the stock in a transaction that occurred on Friday, September 27th. The shares were sold at an average price of $40.19, for a total value of $905,962.98. Following the completion of the sale, the chief financial officer now directly owns 183,076 shares of the company’s stock, valued at approximately $7,357,824.44. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.37% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on OHI shares. Truist Financial raised their price target on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “hold” rating in a report on Wednesday, September 4th. Royal Bank of Canada increased their price objective on Omega Healthcare Investors from $39.00 to $43.00 and gave the company a “sector perform” rating in a report on Monday. BMO Capital Markets lifted their target price on Omega Healthcare Investors from $44.00 to $45.00 and gave the stock a “market perform” rating in a report on Monday, October 7th. Mizuho lowered shares of Omega Healthcare Investors from an “outperform” rating to a “neutral” rating and raised their price target for the stock from $34.00 to $35.00 in a research report on Thursday, July 25th. Finally, Berenberg Bank initiated coverage on shares of Omega Healthcare Investors in a report on Friday, October 18th. They issued a “buy” rating and a $45.00 price objective on the stock. Seven research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to data from MarketBeat, Omega Healthcare Investors currently has a consensus rating of “Hold” and an average target price of $40.00.

Omega Healthcare Investors Stock Up 0.1 %

Shares of OHI opened at $41.39 on Tuesday. The company has a current ratio of 6.48, a quick ratio of 6.48 and a debt-to-equity ratio of 1.10. The firm has a market cap of $11.17 billion, a P/E ratio of 30.43, a PEG ratio of 1.33 and a beta of 0.99. The stock’s 50 day moving average is $40.59 and its two-hundred day moving average is $36.40. Omega Healthcare Investors, Inc. has a 12 month low of $27.53 and a 12 month high of $44.42.

Omega Healthcare Investors Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Monday, November 4th will be given a $0.67 dividend. The ex-dividend date is Monday, November 4th. This represents a $2.68 annualized dividend and a dividend yield of 6.47%. Omega Healthcare Investors’s dividend payout ratio (DPR) is 197.06%.

About Omega Healthcare Investors

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.